Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer

BACKGROUND: Epstein-Barr virus (EBV)-associated gastric cancer (GC) (EBVaGC) is a distinct molecular subtype of GC with a favorable prognosis. However, the exact effects and potential mechanisms of EBV infection on immune checkpoint blockade (ICB) efficacy in GC remain to be clarified. Additionally,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yuezong, Xie, Tong, Wang, Zhenghang, Tong, Shuang, Zhao, Xiaochen, Zhao, Feilong, Cai, Jinping, Wei, Xiaofan, Peng, Zhi, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896035/
https://www.ncbi.nlm.nih.gov/pubmed/35241494
http://dx.doi.org/10.1136/jitc-2021-004080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896035/
https://www.ncbi.nlm.nih.gov/pubmed/35241494
http://dx.doi.org/10.1136/jitc-2021-004080

Ejemplares similares